We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI Inc
GPGI
+$11M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$32.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.66M
3
IHC
Independence Holding Company
IHC
+$3.1M
4
EPD icon
Enterprise Products Partners
EPD
+$2.77M
5
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 19.74%
2 Miscellaneous 15.57%
3 Industrials 15.14%
4 Financials 14.94%
5 Materials 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ONDS icon
26
Ondas Inc
ONDS
$3.7B
$4.96M 0.88%
679,752
+179,752
+36% +$963K
2021 Q3
2 quarters
LSXMA icon
27
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.74M 0.84%
141,002
– –
2020 Q2
7 quarters
AXP icon
28
American Express
AXP
$212B
$4.67M 0.83%
25,000
– –
2019 Q4
9 quarters
CDXS icon
29
Codexis
CDXS
$149M
$4.12M 0.73%
200,000
– –
2019 Q4
9 quarters
JPM icon
30
JPMorgan Chase
JPM
$891B
$4.09M 0.73%
30,000
– –
2019 Q4
9 quarters
FNCH icon
31
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$4.08M 0.72%
27,014
– –
2021 Q1
4 quarters
AENT icon
32
Alliance Entertainment
AENT
$231M
$3.95M 0.7%
400,000
– –
2021 Q2
3 quarters
SONO icon
33
Sonos
SONO
$2.09B
$3.7M 0.66%
131,146
-51,805
-28% -$1.38M
2020 Q4
5 quarters
CUE icon
34
Cue Biopharma
CUE
$136M
$2.69M 0.48%
18,400
+11,733
+176% +$2.49M
2019 Q4
9 quarters
FAZE
35
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.23M 0.4%
225,000
– –
2021 Q2
3 quarters
BRIV
36
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$2.19M 0.39%
225,000
– –
2021 Q3
2 quarters
LBTYK icon
37
Liberty Global Class C
LBTYK
$2.69B
$1.8M 0.32%
69,618
– –
2019 Q4
9 quarters
MXCT icon
38
MaxCyte
MXCT
$134M
$1.76M 0.31%
250,000
– –
2021 Q3
2 quarters
MIST icon
39
Milestone Pharmaceuticals
MIST
$98.9M
$1.6M 0.28%
250,000
– –
2021 Q4
1 quarter
HCAR
40
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$1.47M 0.26%
+150,000
New +$1.47M
2022 Q1
0 quarters
DNTH icon
41
Dianthus Therapeutics
DNTH
$4.17B
$1.41M 0.25%
30,275
– –
2020 Q1
8 quarters
COUR icon
42
Coursera
COUR
$1.35B
$1.24M 0.22%
+53,725
New +$1.1M
2022 Q1
0 quarters
VVNT
43
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$1.23M 0.22%
181,892
-120,351
-40% -$858K
2021 Q3
2 quarters
IRBT icon
44
DELISTED
iRobot
IRBT
$1.21M 0.21%
19,041
-20,230
-52% -$1.28M
2021 Q3
2 quarters
VATE icon
45
INNOVATE Corp
VATE
$84.7M
$1.01M 0.18%
27,480
– –
2020 Q1
8 quarters
PAGS icon
46
PagSeguro Digital
PAGS
$3.07B
$999K 0.18%
+49,829
New +$928K
2022 Q1
0 quarters
XYZ icon
47
Block Inc
XYZ
$48B
$996K 0.18%
7,342
+5,492
+297% +$665K
2021 Q4
1 quarter
TEKK
48
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
$986K 0.18%
100,000
– –
2021 Q4
1 quarter
LRN icon
49
Stride
LRN
$3.46B
$985K 0.17%
27,124
-41,737
-61% -$1.39M
2021 Q3
2 quarters
CRIS icon
50
Curis
CRIS
$1.23M
$921K 0.16%
967
+187
+24% +$239K
2020 Q4
5 quarters
1
2
3 4 5

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

  • Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
  • Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
  • Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.